These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8517786)
1. Accumulation of 1-methyl-tetrahydro-beta-carboline-3-carboxylic acid in blood and organs of rat. A possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. Ogawa Y; Adachi J; Tatsuno Y Arch Toxicol; 1993; 67(4):290-3. PubMed ID: 8517786 [TBL] [Abstract][Full Text] [Related]
2. Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. Adachi J; Yamamoto K; Ogawa Y; Ueno Y; Mizoi Y; Tatsuno Y Arch Toxicol; 1991; 65(6):505-9. PubMed ID: 1929872 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and distribution in the rat of peak E substance, a constituent in L-tryptophan product implicated in eosinophilia-myalgia syndrome. Adachi J; Naito T; Ueno Y; Ogawa Y; Ninomiya I; Tatsuno Y Arch Toxicol; 1993; 67(4):284-9. PubMed ID: 8517785 [TBL] [Abstract][Full Text] [Related]
5. Tetrahydro-beta-carboline-3-carboxylic acids and contaminants of L-tryptophan. Adachi J; Asano M; Ueno Y J Chromatogr A; 2000 Jun; 881(1-2):501-15. PubMed ID: 10905731 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in blood and organs of the Lewis rats. Adachi J; Gomez M; Smith CC; Sternberg EM Arch Toxicol; 1995; 69(4):266-70. PubMed ID: 7755488 [TBL] [Abstract][Full Text] [Related]
7. Identification of tetrahydro-beta-carboline-3-carboxylic acid in foodstuffs, human urine and human milk. Adachi J; Mizoi Y; Naito T; Ogawa Y; Uetani Y; Ninomiya I J Nutr; 1991 May; 121(5):646-52. PubMed ID: 2019874 [TBL] [Abstract][Full Text] [Related]
8. 1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro. Zangrilli JG; Mayeno AN; Vining V; Varga J Biochem Mol Biol Int; 1995 Nov; 37(5):925-33. PubMed ID: 8624499 [TBL] [Abstract][Full Text] [Related]
10. Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: a possible cause of eosinophilia-myalgia syndrome. Yamaguchi Y; Tsunoda J; Suda T; Miura Y; Shioiri-Nakano K; Kasahara T Biochem Biophys Res Commun; 1991 Aug; 178(3):1008-13. PubMed ID: 1872826 [TBL] [Abstract][Full Text] [Related]
11. Identification of four metabolites of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in rats. Adachi J; Mio T; Ueno Y; Naito T; Nishimura A; Fujiwara S; Sumino K; Tatsuno Y Arch Toxicol; 1994; 68(8):500-5. PubMed ID: 7802590 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of tissue distribution and excretion among three substances implicated in eosinophilia-myalgia syndrome. Adachi J; Ueno Y; Tatsuno Y; Gomez M; Smith CC; Sternberg EM Adv Exp Med Biol; 1996; 398():365-70. PubMed ID: 8906290 [No Abstract] [Full Text] [Related]
13. Manipulation of the Precursor Supply in Yeast Significantly Enhances the Accumulation of Prenylated β-Carbolines. Backhaus K; Ludwig-Radtke L; Xie X; Li SM ACS Synth Biol; 2017 Jun; 6(6):1056-1064. PubMed ID: 28221769 [TBL] [Abstract][Full Text] [Related]
14. [A case of the eosinophilia-myalgia syndrome]. Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794 [TBL] [Abstract][Full Text] [Related]
15. On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndrome. Williamson BL; Benson LM; Tomlinson AJ; Mayeno AN; Gleich GJ; Naylor S Toxicol Lett; 1997 Jul; 92(2):139-48. PubMed ID: 9295237 [TBL] [Abstract][Full Text] [Related]
16. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico. Philen RM; Hill RH; Flanders WD; Caudill SP; Needham L; Sewell L; Sampson EJ; Falk H; Kilbourne EM Am J Epidemiol; 1993 Aug; 138(3):154-9. PubMed ID: 8356958 [TBL] [Abstract][Full Text] [Related]
17. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms. Brenneman DE; Page SW; Schultzberg M; Thomas FS; Zelazowski P; Burnet P; Avidor R; Sternberg EM J Pharmacol Exp Ther; 1993 Aug; 266(2):1029-35. PubMed ID: 8355179 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of L-tryptophan impurities in meat products. Lee DH; Kim YH; Baek M; Heo IK; Shin Y Amino Acids; 2023 Feb; 55(2):173-182. PubMed ID: 36588144 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome. Daniels SR; Hudson JI; Horwitz RI J Clin Epidemiol; 1995 Dec; 48(12):1413-27; discussion 1429-40. PubMed ID: 8543957 [TBL] [Abstract][Full Text] [Related]
20. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature. André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]